Radka Hobzova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Radka Hobzova has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Sirc
Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic
11 shared publications - Jiří Michálek
Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic
7 shared publications Jakub Hrib
Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 16206 Prague 6, Czech Republic
3 shared publicationsJan Hrabeta
Charles University in Prague - 2nd Faculty of Medicine
3 shared publications- Miroslava Dušková-Smrčková
Academy of Sciences of the Czech Republic
3 shared publications - Zuzana Bosáková
Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
3 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (84) , e78270
Acetoacetates Derived From Vegetable Oils: A Platform for Tailor‐Made Vinylogous Urethane Foams
The increasing demand for flexible and rigid polyurethane foams has intensified the need for sustainable end‐of‐life management strategies. In this study, a strategy combining vinylogous urethane chemistry with oleochemistry to develop non‐isocyanate, bio‐based polymer foams with enhanced recyclability is employed. This approach presents a universal platform for fabrication of recyclable foams with tunable mechanical properties, ranging from flexible, elastic foams to rigid, stiff materials, owing to the versatile chemistry of vinylogous urethane networks. Moreover, the ability to control gelling and foaming kinetics leads to the fabrication of non‐isocyanate foams with beneficial low‐density (60–70 kg m −3 ) that can compete with typical conventional polyurethane foams. These findings indicate that the vinylogous urethane foams derived from renewable vegetable oils provide a promising strategy for addressing end‐of‐life concerns associated with conventional polyurethane foam applications.
- 10 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (84) , e78270
Open AccessAcetoacetates Derived From Vegetable Oils: A Platform for Tailor‐Made Vinylogous Urethane Foams
The increasing demand for flexible and rigid polyurethane foams has intensified the need for sustainable end‐of‐life management strategies. In this study, a strategy combining vinylogous urethane chemistry with oleochemistry to develop non‐isocyanate, bio‐based polymer foams with enhanced recyclability is employed. This approach presents a universal platform for fabrication of recyclable foams with tunable mechanical properties, ranging from flexible, elastic foams to rigid, stiff materials, owing to the versatile chemistry of vinylogous urethane networks. Moreover, the ability to control gelling and foaming kinetics leads to the fabrication of non‐isocyanate foams with beneficial low‐density (60–70 kg m −3 ) that can compete with typical conventional polyurethane foams. These findings indicate that the vinylogous urethane foams derived from renewable vegetable oils provide a promising strategy for addressing end‐of‐life concerns associated with conventional polyurethane foam applications.
- Open Access
- 3 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1398
Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment
Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
- 3 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1398
Open AccessMultilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment
Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
- Open Access
- 20 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 903
The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant
Transscleral diffusion delivery of chemotherapy is a promising way to reach the vitreal seeds of retinoblastoma, the most common intraocular malignancy in childhood. In this in vivo study, the delivery of topotecan via lens-shaped, bi-layered hydrogel implants was combined with transconjunctival cryotherapy to assess whether cryotherapy leads to higher concentrations of topotecan in the vitreous. The study included 18 New Zealand albino rabbits; nine rabbits received a topotecan-loaded implant episclerally and another nine rabbits received transconjunctival cryotherapy superotemporally 2 weeks before implant administration. Median vitreous total topotecan exposures (area under the curve, AUC) were 455 ng·h/mL for the cryotherapy group and 281 ng·h/mL for the non-cryotherapy group, and were significantly higher in the cryotherapy group, similar to maximum levels. Median plasma AUC were 50 ng·h/mL and 34 ng·h/mL for the cryotherapy and non-cryotherapy groups, respectively, with no statistically significant differences between them. In both groups, AUC values in the vitreous were significantly higher than in plasma, with plasma exposure at only approximately 11–12% of the level of vitreous exposure. The results confirmed the important role of the choroidal vessels in the pharmacokinetics of topotecan during transscleral administration and showed a positive effect of cryotherapy on intravitreal penetration, resulting in a significantly higher total exposure in the vitreous.
- 20 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 903
Open AccessThe Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant
Transscleral diffusion delivery of chemotherapy is a promising way to reach the vitreal seeds of retinoblastoma, the most common intraocular malignancy in childhood. In this in vivo study, the delivery of topotecan via lens-shaped, bi-layered hydrogel implants was combined with transconjunctival cryotherapy to assess whether cryotherapy leads to higher concentrations of topotecan in the vitreous. The study included 18 New Zealand albino rabbits; nine rabbits received a topotecan-loaded implant episclerally and another nine rabbits received transconjunctival cryotherapy superotemporally 2 weeks before implant administration. Median vitreous total topotecan exposures (area under the curve, AUC) were 455 ng·h/mL for the cryotherapy group and 281 ng·h/mL for the non-cryotherapy group, and were significantly higher in the cryotherapy group, similar to maximum levels. Median plasma AUC were 50 ng·h/mL and 34 ng·h/mL for the cryotherapy and non-cryotherapy groups, respectively, with no statistically significant differences between them. In both groups, AUC values in the vitreous were significantly higher than in plasma, with plasma exposure at only approximately 11–12% of the level of vitreous exposure. The results confirmed the important role of the choroidal vessels in the pharmacokinetics of topotecan during transscleral administration and showed a positive effect of cryotherapy on intravitreal penetration, resulting in a significantly higher total exposure in the vitreous.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Establishment of a Xenograft Model of Human Retinoblastoma in Pig Eyes
Retinoblastoma (Rb), the most common primary intraocular tumor in childhood, is specific in its location inside the eye globe and, in more advanced disease, in the occurrence of vitreous seeds. Finding an effective treatment thus requires an adequate tumor animal model. As a large animal model has not yet been described, the purpose of this study was to create a porcine Rb model. Eight male minipigs (8 eyes) without immunosuppression were used in this study. A suspension of cultured WERI-Rb-1 cells, 100 µl with a concentration of 106 cells/ml, was injected into the subretinal space via pars plana vitrectomy (4 eyes) or directly into the vitreous (4 eyes). The animals were examined weekly using a fundus camera, ultrasound and optical coherence tomography. After a period of 4 weeks, the animals were euthanized and enucleated eyes were histopathologically examined. Rb cell growth and the establishment of a tumor under the retina and/or in the vitreous were observed in all 4 eyes after subretinal application and in 2 of 4 eyes after intravitreal application of Rb cells. Tumor growth was detectable with fundoscopy starting at week 1 postinjection. The generation of the tumor was also confirmed histopathologically. The successful creation of Rb tumors in the eyes of nonimmunosuppressed pigs was demonstrated. The porcine xenograft model of Rb with vitreous seeds can serve as a useful platform for testing new treatment modalities in Rb therapy.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessEstablishment of a Xenograft Model of Human Retinoblastoma in Pig Eyes
Retinoblastoma (Rb), the most common primary intraocular tumor in childhood, is specific in its location inside the eye globe and, in more advanced disease, in the occurrence of vitreous seeds. Finding an effective treatment thus requires an adequate tumor animal model. As a large animal model has not yet been described, the purpose of this study was to create a porcine Rb model. Eight male minipigs (8 eyes) without immunosuppression were used in this study. A suspension of cultured WERI-Rb-1 cells, 100 µl with a concentration of 106 cells/ml, was injected into the subretinal space via pars plana vitrectomy (4 eyes) or directly into the vitreous (4 eyes). The animals were examined weekly using a fundus camera, ultrasound and optical coherence tomography. After a period of 4 weeks, the animals were euthanized and enucleated eyes were histopathologically examined. Rb cell growth and the establishment of a tumor under the retina and/or in the vitreous were observed in all 4 eyes after subretinal application and in 2 of 4 eyes after intravitreal application of Rb cells. Tumor growth was detectable with fundoscopy starting at week 1 postinjection. The generation of the tumor was also confirmed histopathologically. The successful creation of Rb tumors in the eyes of nonimmunosuppressed pigs was demonstrated. The porcine xenograft model of Rb with vitreous seeds can serve as a useful platform for testing new treatment modalities in Rb therapy.
- 4 May 2021
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 222 (13) , 2100086
2‐Hydroxyethyl Methacrylate Hydrogels for Local Drug Delivery: Study of Topotecan and Vincristine Sorption/Desorption Kinetics and Polymer‐Drug Interaction by ATR‐FTIR Spectroscopy
Poly(2‐hydroxyethyl methacrylate) (pHEMA) hydrogels are well known in ophthalmological applications and recently investigated as drug delivery systems. The study represents a theoretical approach where the sorption/desorption experiments and spectroscopic study is used to describe the influence of the pHEMA network structure on the sorption capacity and mechanism of the release of topotecan (TPT) and vincristine (VCR). The hydrogels are synthesized by free‐radical crosslinking polymerization of HEMA monomer with ethylene glycol dimethacrylate as a crosslinker in the concentration range from 0.3 to 1 wt%. Experimental data from sorption kinetics are evaluated using sorption kinetic models and sorption isotherms, drug release mechanism is assessed by two different models and attenuated total reflectance Fourier transform infrared (ATR‐FTIR) spectroscopy is employed to describe the polymer‐drug interaction. pHEMA hydrogels exhibit higher affinity for TPT than for VCR and hydrogels prepared with 0.5 wt% of crosslinker show the maximum sorption capacity for both drugs. Physisorption is proved to be the sorption mechanism. Analyzing the FTIR spectra, it is concluded that the hydrophobic crosslinks play an important role in the interaction of the hydrogel backbone with molecules of both drugs.
- 4 May 2021
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 222 (13) , 2100086
2‐Hydroxyethyl Methacrylate Hydrogels for Local Drug Delivery: Study of Topotecan and Vincristine Sorption/Desorption Kinetics and Polymer‐Drug Interaction by ATR‐FTIR Spectroscopy
Poly(2‐hydroxyethyl methacrylate) (pHEMA) hydrogels are well known in ophthalmological applications and recently investigated as drug delivery systems. The study represents a theoretical approach where the sorption/desorption experiments and spectroscopic study is used to describe the influence of the pHEMA network structure on the sorption capacity and mechanism of the release of topotecan (TPT) and vincristine (VCR). The hydrogels are synthesized by free‐radical crosslinking polymerization of HEMA monomer with ethylene glycol dimethacrylate as a crosslinker in the concentration range from 0.3 to 1 wt%. Experimental data from sorption kinetics are evaluated using sorption kinetic models and sorption isotherms, drug release mechanism is assessed by two different models and attenuated total reflectance Fourier transform infrared (ATR‐FTIR) spectroscopy is employed to describe the polymer‐drug interaction. pHEMA hydrogels exhibit higher affinity for TPT than for VCR and hydrogels prepared with 0.5 wt% of crosslinker show the maximum sorption capacity for both drugs. Physisorption is proved to be the sorption mechanism. Analyzing the FTIR spectra, it is concluded that the hydrophobic crosslinks play an important role in the interaction of the hydrogel backbone with molecules of both drugs.
- 1 October 2020
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 115, 111068
Biocompatible indocyanine green loaded PLA nanofibers for in situ antimicrobial photodynamic therapy
- 1 October 2020
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 115, 111068
Biocompatible indocyanine green loaded PLA nanofibers for in situ antimicrobial photodynamic therapy
- Open Access
Hydrogel Tissue Expanders for Stomatology. Part II. Poly(styrene-maleic anhydride) Hydrogels
Self-inflating soft tissue expanders represent a valuable modality in reconstructive surgery. For this purpose, particularly synthetic hydrogels that increase their volume by swelling in aqueous environment are used. The current challenge in the field is to deliver a material with a suitable protracted swelling response, ideally with an induction period (for sutured wound healing) followed by a linear increase in volume lasting several days for required tissue reconstruction. Here, we report on synthesis, swelling, thermal, mechanical and biological properties of novel hydrogel tissue expanders based on poly(styrene-alt-maleic anhydride) copolymers covalently crosslinked with p-divinylbenzene. The hydrogels exerted hydrolysis-driven swelling response with induction period over the first two days with minimal volume change and gradual volume growth within 30 days in buffered saline solution. Their final swollen volume reached more than 14 times the dry volume with little dependence on the crosslinker content. The mechanical coherence of samples during swelling and in their fully swollen state was excellent, the compression modulus of elasticity being between 750 and 850 kPa. In vitro cell culture experiments and in vivo evaluation in mice models showed excellent biocompatibility and suitable swelling responses meeting thus the application requirements as soft tissue expanders.
Open AccessHydrogel Tissue Expanders for Stomatology. Part II. Poly(styrene-maleic anhydride) Hydrogels
Self-inflating soft tissue expanders represent a valuable modality in reconstructive surgery. For this purpose, particularly synthetic hydrogels that increase their volume by swelling in aqueous environment are used. The current challenge in the field is to deliver a material with a suitable protracted swelling response, ideally with an induction period (for sutured wound healing) followed by a linear increase in volume lasting several days for required tissue reconstruction. Here, we report on synthesis, swelling, thermal, mechanical and biological properties of novel hydrogel tissue expanders based on poly(styrene-alt-maleic anhydride) copolymers covalently crosslinked with p-divinylbenzene. The hydrogels exerted hydrolysis-driven swelling response with induction period over the first two days with minimal volume change and gradual volume growth within 30 days in buffered saline solution. Their final swollen volume reached more than 14 times the dry volume with little dependence on the crosslinker content. The mechanical coherence of samples during swelling and in their fully swollen state was excellent, the compression modulus of elasticity being between 750 and 850 kPa. In vitro cell culture experiments and in vivo evaluation in mice models showed excellent biocompatibility and suitable swelling responses meeting thus the application requirements as soft tissue expanders.
- 1 May 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 98, 982-993
Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention
- 1 May 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 98, 982-993
Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention
- 24 April 2018
- Published by Wiley in Macromolecular Bioscience
- Vol. 18 (6) , e1800011
Paclitaxel‐Loaded Polylactide/Polyethylene Glycol Fibers with Long‐Term Antitumor Activity as a Potential Drug Carrier for Local Chemotherapy
Local application of anticancer agents prolongs the presence time and increases the concentration of drug in the target place and therefore may reduce serious side effects compared to drug systemic administration. The preparation of fibrous materials of polylactide (PLA) and polyethylene glycol (PEG) loaded with paclitaxel (PTX, 1 or 10 wt%) is presented. Scanning electron microscopy proves that PTX is homogeneously incorporated into the fibers. The addition of PEG of various molecular weights (6, 20, or 35 kDa) ensures the release of significantly higher amounts of hydrophobic PTX in a prolonged release time compared to the fibers containing PTX only. Present PLA‐PEG fibrous carriers can serve as a drug depot for PTX since they exhibit significant toxicity for cancer cell lines in several‐day experiment. They are promising for local recurrence therapy, where the initial release is efficient to kill tumor cells and continued release can prevent their subsequent proliferation.
- 24 April 2018
- Published by Wiley in Macromolecular Bioscience
- Vol. 18 (6) , e1800011
Paclitaxel‐Loaded Polylactide/Polyethylene Glycol Fibers with Long‐Term Antitumor Activity as a Potential Drug Carrier for Local Chemotherapy
Local application of anticancer agents prolongs the presence time and increases the concentration of drug in the target place and therefore may reduce serious side effects compared to drug systemic administration. The preparation of fibrous materials of polylactide (PLA) and polyethylene glycol (PEG) loaded with paclitaxel (PTX, 1 or 10 wt%) is presented. Scanning electron microscopy proves that PTX is homogeneously incorporated into the fibers. The addition of PEG of various molecular weights (6, 20, or 35 kDa) ensures the release of significantly higher amounts of hydrophobic PTX in a prolonged release time compared to the fibers containing PTX only. Present PLA‐PEG fibrous carriers can serve as a drug depot for PTX since they exhibit significant toxicity for cancer cell lines in several‐day experiment. They are promising for local recurrence therapy, where the initial release is efficient to kill tumor cells and continued release can prevent their subsequent proliferation.
- Open Access
- 17 January 2018
- Published by Wiley in Journal of Nanomaterials
- Vol. 2018, 1-11
Embedding of Bacterial Cellulose Nanofibers within PHEMA Hydrogel Matrices: Tunable Stiffness Composites with Potential for Biomedical Applications
Bacterial cellulose (BC) and poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are both considered as biocompatible materials with potential use in various biomedical applications including cartilage, cardiovascular stent, and soft tissue engineering. In this work, the “ever-wet” process based on in situ UV radical polymerization of HEMA monomer in BC nanofibrous structure impregnated with HEMA was used, and a series of BC-PHEMA composites was prepared. The composite structures were characterized by ATR FT-IR spectroscopy, WAXD, SEM, and TEM techniques. The strategy of using densified BC material of various cellulose fiber contents was applied to improve mechanical properties. The mechanical properties were tested under tensile, dynamic shear, and relaxation modes. The final composites contained 1 to 20 wt% of BC; the effect of the reinforcement degree on morphology, swelling capacity, and mechanical properties was investigated. The biocompatibility test of BC-PHEMA composites was performed using mouse mesenchymal stem cells.
- 17 January 2018
- Published by Wiley in Journal of Nanomaterials
- Vol. 2018, 1-11
Open AccessEmbedding of Bacterial Cellulose Nanofibers within PHEMA Hydrogel Matrices: Tunable Stiffness Composites with Potential for Biomedical Applications
Bacterial cellulose (BC) and poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are both considered as biocompatible materials with potential use in various biomedical applications including cartilage, cardiovascular stent, and soft tissue engineering. In this work, the “ever-wet” process based on in situ UV radical polymerization of HEMA monomer in BC nanofibrous structure impregnated with HEMA was used, and a series of BC-PHEMA composites was prepared. The composite structures were characterized by ATR FT-IR spectroscopy, WAXD, SEM, and TEM techniques. The strategy of using densified BC material of various cellulose fiber contents was applied to improve mechanical properties. The mechanical properties were tested under tensile, dynamic shear, and relaxation modes. The final composites contained 1 to 20 wt% of BC; the effect of the reinforcement degree on morphology, swelling capacity, and mechanical properties was investigated. The biocompatibility test of BC-PHEMA composites was performed using mouse mesenchymal stem cells.